Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease [Phase 1]

View source ↗

Summary

A Phase 1 study to evaluate the safety, tolerability, and effects on blood and urine markers of a single ascending dose of GSK4771261 in healthy participants an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease

Drugs mentioned

• GSK4771261

Snippet

Sponsor: GlaxoSmithKline | Conditions: Kidney Disease | Phase 1 | Status: RECRUITING